Registration has begun! Help raise awareness about ALS and raise money to fund worldwide ALS research to develop new treatments and a cure.
The Packard Center for ALS Research at Johns Hopkins enables the world’s best ALS scientists to collaborate and access funding so that they may continue work to rapidly develop new treatments and find a cure for ALS, also known as Lou Gehrig’s disease. The hope is in the science. Get Involved. >>
Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.
Tue, 02 Feb 2010 18:03:25 GMThttp://www.alscenter.org/news/rss_als_headlines/10_02_02.html
Doctors injected stem cells from 8-week-old fetal tissue into the spine of a man in his early 60s who has advanced ALS, or amyotrophic lateral sclerosis.
Fri, 22 Jan 2010 20:37:47 GMThttp://www.alscenter.org/news/rss_als_headlines/10_01_21_cnn.html
Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.
Thu, 21 Jan 2010 04:20:33 GMThttp://www.alscenter.org/news/rss_als_headlines/10_10_15_sd.html
A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS), scientists report after completing a Phase II clinical trial.
Thu, 21 Jan 2010 04:15:18 GMThttp://www.alscenter.org/news/rss_als_headlines/10_01_14.html
J.P. Morgan Chase has teamed up with Facebook
to launch a ground-breaking charitable initiative. Log on and vote for AMND from January 15 - 22nd and spread the word!
Fri, 15 Jan 2010 21:05:53 GMThttp://www.alscenter.org/news/rss_als_headlines/10_01_15b.html
Project A.L.S. and the Robert Packard Center for ALS Research at Johns Hopkins will partner on P2 ALS, a $15 million initiative designed to advance ALS research exponentially over the next three years.
Fri, 29 Jan 2010 16:03:47 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_29.html
This February, a new entry in the ALS clinical trials system will have top scientists watching intently for results. It’s the start of human tests of a therapy based on a totally new principle—one that works by silencing mutant genes.
Thu, 28 Jan 2010 17:54:15 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_28.html
Right now, there's no quick, reliable way to tell if something has stopped or slowed ALS down. Packard expertise helps bring an easily measured biomarker closer.
Sun, 27 Dec 2009 03:47:41 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/09_12_15.html
Stay Connected
Sign up for e-mail updates by submitting your email address here.
